Conversely, p53 demonstrates bidirectional effects: wild-type p53 promotes ferroptosis by inhibiting SLC7A11 transcription, while certain mutant variants safeguard cancer cells, notably by augmenting NRF2 signaling—an effect observed in triple-negative breast cancer (TNBC) [43,44]. The gene discussed is TP53; the disease is triple-negative breast carcinoma.